Featured Videos

An Expert’s Perspective on the Expanded Approval of Venetoclax

Dr. Susan O’Brien discusses the exciting new data propelling the recent approval for the expanded use of venetoclax and the impact it will have on those living with CLL.

Published:

Considering FCR? What You Should Know Before Starting Chemotherapy

Dr. Nicole Lamanna gives an expert perspective on what CLL patients should be aware of, including the risks, benefits and other treatment options, before starting an FCR chemotherapy regimen.

Published:

An AML Treatment Revolution: Updates From an Expert

Dr. Naval Daver from The University of Texas MD Anderson Cancer Center joined Patient Power to discuss the dramatic progress being made in therapies for acute myeloid leukemia (AML).

Published:

Blindsided by a Second Cancer

How can patients cope with facing a second cancer? What lessons learned from the first can be applied to this new treatment journey? Watch now to find out first-hand from patient advocate Carol Preston.

Published:

Chemo vs. Transplants: What Is the Purpose and Value of Each AML Treatment Method?

There are several treatment methods used for AML patients, but which one is right for you? AML expert Dr. Gwen Nichols gives information on procedure, purpose and value to help patients find the best approach.

Published:

Children Diagnosed With ALL Have a Good Chance of Success With Current Treatments

Dr. Stephan Grupp from The Children’s Hospital of Philadelphia, Philadelphia talks about the success rates of acute lymphocytic leukemia in children.

Published:

Advertisement
tritt unserer Gemeinschaft bei Registrieren Sie sich für Veranstaltungen Lesen Sie unseren neuesten Blog
Advertisement

Page last updated on August 15, 2018